Skip to main content
SpringerLink
Log in

Long-term treatment with β-blockers after myocardial infarction

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

162 patients discharged from hospital after myocardial infarction were randomly allocated to two groups, one received alprenolol 400 mg daily and the other served as the control. The period of follow-up was two years and all other treatment given was standardized. The two groups did not differ with respect to risk factors for myocardial infarction, the course of the acute infarct or treatment during follow-up. After two years one patient in the group treated with alprenolol had died suddenly as compared to nine in the control group. During the same period four fresh infarcts had occurred in the alprenolol group compared to 15 in the control group. Both these differences were statistically significant. Only four patients were obliged to discontinue β-blocker treatment because of suspected side-effects. Long-term post-infarction treatment with β-blockers appears to be an effective form of secondary therapy without serious side-effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ahlmark, G., Saetre, H., Korsgren, M.: Reduction of sudden deaths after myocardial infarction. Lancet1974 II, 1563

    Google Scholar 

  2. Amsterdam, E.A., Wolfson, S., Gorlin, R.: Effect of therapy on survival in angina pectoris. Ann. Intern. Med.68, 1151 (1968)

    Google Scholar 

  3. DeMaria, A.N., Vera, Z., Amsterdam, E.A.: Disturbances of cardiac rhythm and conduction induced by exercise: diagnostic, prognostic and therapeutic implications. Amer. J. Cardiol.33, 732–736 (1974)

    Google Scholar 

  4. Fox, K.M., Chopra, M.P., Portal, R.W., Aber, C.P.: Long-term beta blockade; possible protection from myocardial infarction. Brit. med. J.1975 I, 117–119

    Google Scholar 

  5. Fredrickson, D.S., Lees, R.S.: A system for phenotyping hyperlipoproteinemia. Circulation31, 321–327 (1965)

    Google Scholar 

  6. Gibson, D., Sowton, E.: The use of beta-adrenergic receptor blocking drugs in dysrhythmias. Progress of cardiovascular disease12, 16–39 (1969)

    Google Scholar 

  7. Gilliam, P.M.S., Prichard, B.N.C.: Propranolol in the therapy of angina pectoris. Amer. J. Cardiol.18, 366–369 (1966)

    Google Scholar 

  8. Hickie, J.B., Bernstein, L., Cutforth, R., Donnelly, G.L., Hetzel, P., McCredie, J.M., Morgan, J., Neilsen, G., Pitts, A., Seldon, W.A.: Alprenolol in angina pectoris. A double blind multicentre trial. Aust. Ann. Med.19, 190 (1970)

    Google Scholar 

  9. Jonsell, S.: A method for determination of the heart size by teleroentgenography (a heart volume index). Acta radiol. (Stockh.)20, 325–340 (1939)

    Google Scholar 

  10. Kosowsky, B.D., Taylor, J., Lown, B., Ritchie, R.F.: Long-term use of procainamide following acute myocardial infarction. Circulation47, 1204–1210 (1973)

    Google Scholar 

  11. Lown, B.: Sudden death from ischemic heart disease. Skandia International Symposia 1972

  12. Norris, R.M., Mercier, C.I.: Long term prognosis following treatment in a coronary-care unit. Aust. N.Z. J. Med.1, 31–37 (1973)

    Google Scholar 

  13. Pell, S., d'Alonzo, C.A.: Immediate mortality and five-year survival of employed men with a first myocardial infarction. New Engl. J. Med.270, 915–922 (1964)

    Google Scholar 

  14. Reynolds, J.L., Whitlock, R.M.L.: Effects of a beta-adrenergic receptor-blocker in myocardial infarction treated for one year from onset. Brit. Heart J.34, 252–259 (1972)

    Google Scholar 

  15. Romo, M.: Factors related to sudden deaths in acute ischemic heart disease. Acta med. scand. Suppl.547, 1–92 (1973)

    Google Scholar 

  16. Ryan, M., Lown, B., Horn, H.: Comparison of ventricular ectopic activity during 24-hour monitoring and exercise testing in patients with coronary heart disease. New Engl. J. Med.292, 224–229 (1975)

    Google Scholar 

  17. Vedin, J.A., Wilhelmsson, C.E., Elmfeldt, D., Tibblin, G., Wilhelmsen, L., Werkö, L.: Sudden death. Identification of high risk groups. Amer. Heart J.86, 1, 124–132 (1973)

    Google Scholar 

  18. Wilhelmsson, C., Vedin, J.A., Wilhelmsen, L., Tibblin, G., Werkö, L.: Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Lancet 1974II, 1157–1160

    Google Scholar 

  19. Collaborative group: Phenytoin after recovery from myocardial infarction. Lancet1971 II, 1055–1057

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Department, Falu Hospital, Falun, Sweden

    G. Ahlmark & H. Saetre

Authors
  1. G. Ahlmark
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Saetre
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ahlmark, G., Saetre, H. Long-term treatment with β-blockers after myocardial infarction. Eur J Clin Pharmacol 10, 77–83 (1976). https://doi.org/10.1007/BF00609463

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00609463

Key words

Search

Navigation